Visipaque 270mg/ml Inj, 50ml

Manufacturer GE HEALTHCARE Active Ingredient Iodixanol(EYE oh dix an ole) Pronunciation EYE-oh-DIX-an-ol
WARNING: This drug is given as a shot into a vein or artery only.This drug must not be given into the spine.Very bad health problems, paralysis, and death have happened when contrast has been given into blood vessels in the spinal cord. Talk with the doctor. @ COMMON USES: It is used before a CT scan or other test.
đŸˇī¸
Drug Class
Diagnostic Agent
đŸ§Ŧ
Pharmacologic Class
Iodinated Contrast Media, Non-ionic, Iso-osmolar
🤰
Pregnancy Category
Category B
✅
FDA Approved
May 1999
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Iodixanol is a special dye used during X-ray tests like CT scans or angiograms. It helps doctors see your blood vessels, organs, and other body parts more clearly. It's injected into your vein and then quickly travels through your body, making the areas of interest show up better on the images.
📋

How to Use This Medicine

Taking Your Medication Correctly

To ensure safe and effective use, take this medication exactly as directed by your doctor. Carefully read all the information provided to you and follow the instructions closely. This medication is administered via injection into a vein or artery only.

Before receiving this medication, it is essential to be properly hydrated. Consult your doctor to determine if you need to drink additional fluids before the injection. After receiving the medication, drink plenty of non-caffeinated liquids unless your doctor advises you to limit your fluid intake. In some cases, other medications may be given before this medication to help minimize side effects.

Storage and Disposal

This injection will be administered in a healthcare setting, and you will not need to store it at home.

Missed Dose

Since this medication is given in a healthcare setting, you will not need to worry about missing a dose. The healthcare provider will administer the medication as scheduled.
💡

Lifestyle & Tips

  • Drink plenty of fluids before and after the procedure, especially if you have kidney problems, to help flush the dye out of your system and protect your kidneys.
  • Inform your healthcare provider about all your medications, especially metformin, and any allergies you have, particularly to iodine or previous contrast dyes.
  • Follow all pre-procedure instructions regarding fasting or medication adjustments.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable based on procedure and patient weight. Typical doses for CT angiography range from 75-150 mL.
Dose Range: 20 - 200 mg

Condition-Specific Dosing:

CT_Head: 50-150 mL (e.g., 100 mL for 70 kg patient)
CT_Body: 75-150 mL (e.g., 125 mL for 70 kg patient)
Angiography: 20-200 mL depending on vessel and number of injections
Urography: 50-100 mL
đŸ‘ļ

Pediatric Dosing

Neonatal: 0.5-4 mL/kg, not to exceed 4 mL/kg or 150 mL total, depending on procedure.
Infant: 0.5-4 mL/kg, not to exceed 4 mL/kg or 150 mL total, depending on procedure.
Child: 0.5-4 mL/kg, not to exceed 4 mL/kg or 150 mL total, depending on procedure.
Adolescent: 0.5-4 mL/kg, not to exceed 4 mL/kg or 150 mL total, depending on procedure. May approach adult doses for larger adolescents.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment; ensure adequate hydration.
Moderate: No specific dose adjustment; ensure adequate hydration. Closely monitor renal function.
Severe: No specific dose adjustment; use with caution. Ensure adequate hydration. Consider alternative imaging if possible. Closely monitor renal function for contrast-induced nephropathy (CIN).
Dialysis: Can be administered to patients on dialysis. Dialysis can remove iodixanol, but the timing of dialysis post-administration is not critical for removal of the contrast agent itself, but rather for managing fluid and electrolyte balance. Consider administering just prior to dialysis session.

Hepatic Impairment:

Mild: No adjustment
Moderate: No adjustment
Severe: No adjustment

Pharmacology

đŸ”Ŧ

Mechanism of Action

Iodixanol is a non-ionic, iso-osmolar, dimeric iodinated contrast medium. It enhances visualization of structures and fluids in the body by absorbing X-rays. When injected intravascularly, it distributes into the extracellular fluid space and provides contrast enhancement based on iodine concentration. Its iso-osmolality (similar to human plasma) is thought to contribute to a lower incidence of adverse events compared to hyperosmolar contrast agents.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (following intravenous administration)
Tmax: Immediately after injection
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: Approximately 0.26 L/kg (similar to extracellular fluid volume)
ProteinBinding: < 2%
CnssPenetration: Limited (does not cross intact blood-brain barrier)

Elimination:

HalfLife: Approximately 2 hours
Clearance: Approximately 110 mL/min
ExcretionRoute: Primarily renal (glomerular filtration)
Unchanged: > 97% in urine within 24 hours
âąī¸

Pharmacodynamics

OnsetOfAction: Immediate (upon injection)
PeakEffect: Immediate (upon injection, then declines as it distributes and is eliminated)
DurationOfAction: Minutes to hours, depending on blood flow to the area of interest and renal function (typically 5-15 minutes for peak enhancement in vascular structures, longer for urinary tract)

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Rarely, allergic reactions can be fatal.
Signs of kidney problems, including:
+ Inability to urinate or changes in urine output
+ Blood in the urine or significant weight gain
Signs of thyroid problems, such as:
+ Weight changes
+ Feeling nervous, excitable, restless, or weak
+ Hair thinning or depression
+ Eye or neck swelling
+ Difficulty focusing or trouble with heat or cold
+ Menstrual changes
+ Shakiness or sweating
Chest pain or pressure, rapid or irregular heartbeat
Severe dizziness or fainting
Swelling, warmth, numbness, color changes, or pain in a leg or arm
Weakness on one side of the body, trouble speaking or thinking, balance changes, drooping on one side of the face, or blurred vision
If the medication leaks from the vein, it can cause tissue damage. Inform your nurse if you experience redness, burning, pain, swelling, blisters, skin sores, or fluid leakage at the injection site.
Severe skin reactions can occur anywhere from 1 hour to several weeks after receiving this medication, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect internal organs and be life-threatening
If you experience any of the following symptoms, seek medical help immediately:
+ Red, swollen, blistered, or peeling skin
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, eyes, genitals, or skin
+ Fever, chills, body aches, shortness of breath, or swollen glands

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you are concerned about any of the following side effects or if they persist, contact your doctor:

Feeling of warmth
* Irritation at the injection site

This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Any rash, itching, or hives after the procedure
  • Swelling of your face, lips, or tongue
  • Difficulty breathing or wheezing
  • Dizziness or feeling faint
  • Severe nausea or vomiting
  • Unusual pain or swelling at the injection site
  • Decreased urination or swelling in your legs/ankles (signs of kidney problems)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently dehydrated, have been experiencing poor nutrition, or have recently used a laxative or diuretic (water pill).
If you have had a skin reaction to this medication or a similar medication in the past.
If you are taking metformin, as this may interact with the medication.

This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your existing medications and health conditions.

Remember, do not start, stop, or change the dose of any medication without first consulting your doctor to ensure your safety.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions for Patients Taking This Medication

If you are taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, about your treatment. Your doctor may need to monitor your blood work regularly, so be sure to discuss this with them.

Although rare, this medication can cause life-threatening or fatal heart problems, including low blood pressure and heart attack. It is crucial to talk to your doctor about these potential risks.

Additionally, when used in conjunction with certain procedures, this medication can increase the risk of blood clots, which may lead to heart attack and stroke, potentially resulting in death. If you have any questions or concerns, consult your doctor.

This medication may also interfere with certain laboratory tests. Therefore, it is vital to inform all your child's healthcare providers and laboratory personnel that they are taking this medication.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

Pregnant or breastfeeding women, or those planning to become pregnant, should discuss the benefits and risks of this medication with their doctor.

Special Considerations for Children

When administering this medication to children, use caution, as the risk of side effects may be higher in some pediatric patients. In children under 3 years of age, the use of medications like this one has been associated with low thyroid function, which can impact child development. Your child's doctor may recommend regular thyroid function checks for an extended period after the injection. If you have any questions or concerns, consult your child's doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Fluid overload (pulmonary edema, heart failure)
  • Electrolyte disturbances
  • Acute renal failure
  • Severe hypersensitivity reactions

What to Do:

Treatment is symptomatic and supportive. Monitor vital signs, fluid and electrolyte balance. Hemodialysis can be used to remove iodixanol in cases of severe overdose or renal failure. Call 1-800-222-1222 (Poison Control).

Drug Interactions

🔴

Major Interactions

  • Metformin (in patients with renal impairment or acute kidney injury): Risk of lactic acidosis. Metformin should be withheld at the time of or prior to the procedure and for 48 hours after, and reinstituted only after renal function is stable.
  • Interleukin-2 (IL-2): Increased risk of delayed adverse reactions (e.g., fever, rash, flu-like symptoms, renal dysfunction) due to altered contrast distribution and elimination.
🟡

Moderate Interactions

  • Beta-blockers: May blunt the compensatory cardiovascular responses to anaphylaxis, making treatment of severe hypersensitivity reactions more difficult.
  • Diuretics: May increase the risk of dehydration and subsequent contrast-induced nephropathy, especially in patients with pre-existing renal impairment.
  • Nephrotoxic drugs (e.g., NSAIDs, aminoglycosides): Concomitant use may increase the risk of contrast-induced nephropathy.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal Function (Serum Creatinine, eGFR)

Rationale: To assess baseline kidney function and identify patients at risk for contrast-induced nephropathy (CIN).

Timing: Prior to contrast administration (within 30 days, ideally within 7 days for high-risk patients).

Allergy History

Rationale: To identify prior reactions to contrast media or other allergens, guiding pre-medication strategies.

Timing: Prior to contrast administration.

Hydration Status

Rationale: Adequate hydration is crucial for preventing CIN.

Timing: Prior to contrast administration.

Thyroid Function (TSH, T4)

Rationale: Iodinated contrast can induce hyperthyroidism in susceptible individuals (e.g., those with latent hyperthyroidism or autonomous thyroid nodules).

Timing: Consider in patients with known thyroid disease or risk factors.

📊

Routine Monitoring

Vital Signs (BP, HR, RR, O2 Sat)

Frequency: Before, during, and immediately after injection, then as clinically indicated for 30-60 minutes.

Target: Within patient's normal range

Action Threshold: Significant deviations (e.g., hypotension, tachycardia, bradycardia, respiratory distress) require immediate intervention.

Signs/Symptoms of Hypersensitivity Reaction

Frequency: Continuously monitored during and for at least 30-60 minutes post-injection, and patient advised to report delayed reactions.

Target: Absence of symptoms

Action Threshold: Any signs of rash, urticaria, pruritus, angioedema, bronchospasm, hypotension, or anaphylaxis require immediate medical attention.

Renal Function (Serum Creatinine, eGFR)

Frequency: 24-72 hours post-procedure for high-risk patients (e.g., pre-existing renal impairment, diabetes, heart failure, dehydration, concomitant nephrotoxic drugs).

Target: Stable or returning to baseline

Action Threshold: Increase in serum creatinine by â‰Ĩ 0.3 mg/dL or â‰Ĩ 50% from baseline within 48-72 hours indicates CIN.

đŸ‘ī¸

Symptom Monitoring

  • Rash
  • Hives (urticaria)
  • Itching (pruritus)
  • Swelling of face, lips, tongue, or throat (angioedema)
  • Difficulty breathing or wheezing (bronchospasm)
  • Dizziness or lightheadedness
  • Nausea
  • Vomiting
  • Headache
  • Fever
  • Chills
  • Flu-like symptoms (delayed reactions)
  • Decreased urine output (sign of CIN)
  • Flank pain (sign of CIN)

Special Patient Groups

🤰

Pregnancy

Category B. Animal studies have not shown harm to the fetus. There are no adequate and well-controlled studies in pregnant women. Use only if clearly needed and the potential benefits outweigh the potential risks.

Trimester-Specific Risks:

First Trimester: No specific increased risk identified beyond general pregnancy considerations for diagnostic procedures.
Second Trimester: No specific increased risk identified.
Third Trimester: No specific increased risk identified. Fetal thyroid function should be monitored if exposure occurs in late pregnancy due to theoretical risk of transient hypothyroidism.
🤱

Lactation

L2 (Likely Compatible). Minimal amounts of iodixanol are excreted into breast milk. The amount absorbed by the infant is very low. Breastfeeding can generally be continued without interruption. If concerns exist, a temporary interruption of breastfeeding for 12-24 hours after administration can be considered, but is usually not necessary.

Infant Risk: Low risk of adverse effects to the breastfed infant.
đŸ‘ļ

Pediatric Use

Dosing is weight-based. Children, especially neonates and infants, are more susceptible to fluid and electrolyte imbalances and temperature dysregulation. Careful monitoring of hydration status and vital signs is essential. Risk of thyroid dysfunction (transient hypothyroidism) may be higher in neonates and infants, especially premature infants.

👴

Geriatric Use

No specific dose adjustment is required based on age alone. However, elderly patients are more likely to have pre-existing renal impairment, heart failure, or diabetes, increasing their risk for contrast-induced nephropathy. Careful assessment of renal function and hydration status is crucial. Use the lowest effective dose.

Clinical Information

💎

Clinical Pearls

  • Iodixanol is iso-osmolar to human plasma, which may lead to a lower incidence of discomfort, pain, and adverse events (e.g., nausea, vomiting, heat sensation) compared to hyperosmolar contrast agents.
  • Often preferred for patients at higher risk for contrast-induced nephropathy (CIN), severe allergic reactions, or those with cardiac conditions, although adequate hydration remains the primary preventative measure for CIN.
  • Crucial to ensure adequate hydration before and after administration, especially in patients with risk factors for CIN.
  • Always inquire about metformin use and ensure appropriate withholding and re-initiation protocols are followed to prevent lactic acidosis.
  • Be prepared for immediate treatment of hypersensitivity reactions, even with non-ionic agents, as they can still occur.
🔄

Alternative Therapies

  • Iohexol (Omnipaque)
  • Iopamidol (Isovue)
  • Iopromide (Ultravist)
  • Ioversol (Optiray)
  • Gadolinium-based contrast agents (for MRI, different mechanism)
  • Barium sulfate (for GI tract imaging, different route/use)
💰

Cost & Coverage

Average Cost: Highly variable, typically $100-$300 per 50 mL vial per 50 mL vial
Insurance Coverage: Generally covered by medical insurance for diagnostic imaging procedures, often Tier 3 or higher due to brand name and specialized use.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of the reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, do not flush medications down the toilet or pour them down the drain. If you are unsure about the proper disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the quantity, and the time of ingestion.